HEAL Rapport du Comité
Si vous avez des questions ou commentaires concernant l'accessibilité à cette publication, veuillez communiquer avec nous à accessible@parl.gc.ca.
LISTE DES RECOMMANDATIONS
Le Comité recommande que :
1. |
Santé Canada apporte les modifications qui s’imposent au Programme d’accès spécial afin |
|
|
|
|
|
a) |
que les coûts qui constituent un fardeau indu pour un patient soient assumés par le gouvernement fédéral et |
|
b) |
que le fardeau bureaucratique soit réduit; |
|
|
|
2. |
Santé Canada fasse chaque année rapport au Comité permanent de la santé, par l’entremise de la Chambre des communes, sur la situation des insulines animales et de l’insuline humaine recombinée; |
|
|
|
|
3. |
Health
Canada request significant advance notice from Eli Lilly, (for example,
five years), on any change in the company’s policy regarding the
provision of animal-sourced insulins; |
|
|
|
|
4. |
Health
Canada, in partnership with the Canadian Food Inspection Agency,
facilitate the work done by Eli Lilly through active support for various
measures, including the provision of tissue for insulin purification
through the relationship established between the Agency and the abattoirs; |
|
|
|
|
5. |
Health
Canada work closely with the Food and Drug Administration of the United
States such that a concerted strategy is developed to ensure a North
American supply of animal-sourced insulins; and |
|
|
|
|
6. |
Health
Canada work closely with the Canadian Medical Association, the Royal
College of Physicians and Surgeons of Canada and other professional bodies
to ensure that the use of animal-sourced insulins is an option considered
in the education and subsequent practice of physicians. |